AstraZeneca vs Viking Therapeutics: Revenue Comparison
AstraZeneca (AZN) and Viking Therapeutics (VKTX) are peers in GLP-1. AstraZeneca reported revenue of $15.3B as of Q1 2026, compared with $0 for Viking Therapeutics. AstraZeneca leads on revenue.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: AstraZeneca 15.288, Viking Therapeutics 0.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, AstraZeneca, Viking Therapeutics.| Metric | AstraZeneca | Viking Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.29B | $0 |
| Cost of Revenue | $2.68B | $0 |
| Gross Profit | $12.61B | $0 |
| Operating Income | $4.25B | $-164.00M |
| Net Income | $3.08B | $-158.00M |
| R&D Expense | $3.49B | $150.00M |
| Earnings Per Share | $3.94 | -$1.37 |
| Gross Margin | 82.5% | - |
| Operating Margin | 27.8% | - |
| Net Profit Margin | 20.1% | - |
| Free Cash Flow | $1.82B | $-114.00M |
| Cumulative Free Cash Flow | $119.09B | $-747.00M |
| Operating Cash Flow | $3.36B | $-114.00M |
| Cash & Equivalents | $7.56B | $118.00M |